1 – 2 of 2 jobs
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Our client is a globally active organization based in the Basel region, known for its collaborative culture and commitment to operational excellence. To ensure continuity in their finance function, they are seeking interim support within Accounts
